CHF6467 Part 2 (MAD): Clinical Trials

1 trial of CHF6467 Part 2 (MAD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow CHF6467 Part 2 (MAD): new trials by email Literature Review of CHF6467 Part 2 (MAD) trials Research Report on CHF6467 Part 2 (MAD)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Safety, Side Effects and How the Drug CHF6467 Administered Via Intranasal Route is Absorbed, Modified and Removed in Healthy Subjects
CHF6467 Part 1 (SAD), CHF6467 Part 2 (MAD), Placebo - Healthy Volunteers
Phase 1RecruitingChiesi Farmaceutici S.p.A.682025-09-152026-09-17

Sponsors

Chiesi Farmaceutici S.p.A. (1)

Countries

Bulgaria (1)

Top investigators

Maya Dabcheva, MD (1)

NIH funding

2025 (1)